flag
Search

Blogs & News

Welcome

Explore all that Huvepharma, Inc. has to offer!  Like us on Facebook and subscribe to our Youtube channel.

Huvepharma® Returns the only FDA-Approved Triple-Sulfa Medication to Market

Huvepharma®, Inc. is re-launching PoultrySulfa® (sulfamerazine, sulfamethazine and sulfaquinoxaline), bringing back the only FDA-approved triple-sulfa veterinary product available to the animal health market.

Huvepharma®, Inc. continues to grow with several new hires across multiple departments.

Peachtree City, GA (February 18th, 2022) – Huvepharma® is pleased to announce that Ed Bell, Tracy Harris Ⅲ, Doug Rupp and Dr. Doug Braun have joined the team since the beginning of the new year.

Huvepharma® Receives FDA Approval for Tilmovet® AC (tilmicosin phosphate)

Peachtree City, GA (February 9th, 2022) – Huvepharma® announces FDA approval for Tilmovet® AC (tilmicosin phosphate)

Huvepharma® announces Monovet® (monensin Type A medicated article) medicated feed combination approvals

The first FDA-approved generic monensin – available to U.S. beef, dairy, and goat producers as Monovet®90 (monensin Type A medicated article) from global animal health company Huvepharma®  – has now also received FDA approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.

1 2 3 4 5 7
9-12 of 28 results